0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.05
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$116.14M
Reddito:
$1.50M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
0.00
EPS:
-1.67
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Leap Therapeutics Inc Stock (LPTX) Company Profile
Nome
Leap Therapeutics Inc
Settore
Industria
Telefono
617 252 4343
Indirizzo
47 THORNDIKE STREET, CAMBRIDGE, MA
Compare LPTX vs VRTX, REGN, ALNY, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LPTX
Leap Therapeutics Inc
|
0.00 | 116.14M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.00 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
732.87 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.17 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
663.93 | 41.09B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ONC
Beone Medicines Ltd Adr
|
275.28 | 30.56B | 5.36B | 287.73M | 924.18M | 2.5229 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2021-10-04 | Iniziato | Mizuho | Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2020-06-29 | Iniziato | Piper Sandler | Overweight |
| 2020-02-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | Ripresa | Raymond James | Outperform |
| 2017-03-07 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Leap Therapeutics Inc Borsa (LPTX) Ultime notizie
Published on: 2026-03-19 01:39:58 - baoquankhu1.vn
Can Leap Therapeutics Inc stock outperform in a bear marketWeekly Profit Recap & Fast Moving Trade Plans - baoquankhu1.vn
Leap Therapeutics (LPTX) Stock Price, News & Analysis $LPTX - MarketBeat
Leap Therapeutics (NASDAQ:LPTX) Trading Up 368.6% – Still a Buy? - Defense World
Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart
LPTX SEC FilingsLeap Therapeutic 10-K, 10-Q, 8-K Forms - Stock Titan
Leap Therapeutics, Inc. Common Stock (CYPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Leap Therapeutics, Inc.Common Stock (NQ: LPTX - The Chronicle-Journal
Downgrade Watch: What is ONTOs TAM Total Addressable Market2025 Analyst Calls & Weekly Setup with High ROI Potential - baoquankhu1.vn
Can Leap Therapeutics Inc deliver consistent dividendsMarket Activity Report & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Chart Watch: Can Leap Therapeutics Inc withstand a market correction2025 Institutional Moves & Daily Market Momentum Tracking - baoquankhu1.vn
Momentum Shift: Whats the beta of Leap Therapeutics Inc stockQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Big Money Moves: Is Sohucom Limited Depositary Receipt exposed to currency risksWeekly Gains Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Can Leap Therapeutics Inc. deliver consistent dividendsStop Loss & AI Based Trade Execution Alerts - mfd.ru
Can Leap Therapeutics Inc. stock beat market expectations this quarterRecession Risk & AI Driven Stock Price Forecasts - mfd.ru
Can Leap Therapeutics Inc. (5MC) stock stage a strong rebound this quarterJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru
Weekly Recap: Is Leap Therapeutics Inc a top pick in the sectorPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Can Leap Therapeutics Inc withstand a market correctionJuly 2025 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
EV Market: Will Leap Therapeutics Inc outperform tech stocksMarket Risk Analysis & Accurate Intraday Trade Tips - baoquankhu1.vn
Leap Therapeutics (NASDAQ:LPTX) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS) Financial Contrast - Defense World
Pharma News: Is Altisource Portfolio Solutions SA Equity Warrant being accumulated by smart moneyStop Loss & Safe Entry Trade Reports - baoquankhu1.vn
Leap Therapeutics Stock More Than Doubles On Zcash Treasury Pivot – Former POTUS Advisor Calls It ‘Gangster’ Move - MSN
Analyzing Leap Therapeutics (NASDAQ:LPTX) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Earnings Beat: Can Leap Therapeutics Inc stock outperform in a bear market2025 Volatility Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
Published on: 2026-01-18 21:43:08 - baoquankhu1.vn
Critical Review: Pharmaxis (OTCMKTS:PXSLY) vs. Leap Therapeutics (NASDAQ:LPTX) - Defense World
Leap Therapeutics Is Going Wild: Is LPTX The Next Biotech Moonshot Or Just Hype? - AD HOC NEWS
Stock Recap: Can Leap Therapeutics Inc ride the EV waveEarnings Overview Report & High Yield Equity Trading Tips - baoquankhu1.vn
Can Leap Therapeutics Inc disrupt its industry2025 Momentum Check & Community Shared Stock Ideas - baoquankhu1.vn
US Market Wrap: How Leap Therapeutics Inc stock compares to growth peers2025 Market Overview & Verified Momentum Stock Alerts - Bộ Nội Vụ
Institution Moves: Is Leap Therapeutics Inc. stock near bottom after declineWeekly Trade Review & Reliable Entry Point Alerts - Bộ Nội Vụ
How Leap Therapeutics Inc. stock performs after earningsTrail vs Road Selection & HOKA model picks for your routine - Улправда
How Leap Therapeutics Inc. stock reacts to bond yieldsWeekly Market Outlook & Community Trade Idea Sharing - Улправда
How Leap Therapeutics Inc. stock reacts to job market dataNew Guidance & Expert Verified Stock Movement Alerts - ulpravda.ru
Can Leap Therapeutics Inc. stock maintain operating marginsJuly 2025 Levels & Precise Swing Trade Alerts - ulpravda.ru
CEO Moves: Will Leap Therapeutics Inc stock split attract more investorsDollar Strength & AI Driven Price Predictions - moha.gov.vn
Gainers Report: Will Leap Therapeutics Inc stock split attract more investorsProduct Launch & AI Based Buy and Sell Signals - moha.gov.vn
Reviewing Leap Therapeutics (NASDAQ:LPTX) and Vincerx Pharma (NASDAQ:VINC) - Defense World
Published on: 2025-12-26 06:38:32 - moha.gov.vn
Does Leap Therapeutics Inc. stock trade at a discount to peersGlobal Markets & Entry Point Strategy Guides - Улправда
Aug Decliners: Does Leap Therapeutics Inc. stock trade at a discount to peersEarnings Beat & Daily Oversold Stock Bounce Ideas - Улправда
Why Leap Therapeutics Inc. (5MC) stock is favored by hedge fundsQuarterly Investment Review & AI Based Buy and Sell Signals - Улправда
Is Leap Therapeutics Inc. stock near bottom after declineShare Buyback & Consistent Return Investment Signals - Улправда
Will Leap Therapeutics Inc. stock attract ESG investorsTrade Performance Summary & Reliable Entry Point Trade Alerts - Улправда
Why Leap Therapeutics Inc. stock is a must watch in 2025Weekly Profit Summary & Weekly Setup with High ROI Potential - Улправда
Is Leap Therapeutics Inc. stock a bargain at current levelsJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - DonanımHaber
VIX Spike: Does Leap Therapeutics Inc. stock trade at a discount to peersJuly 2025 Price Swings & Daily Momentum Trading Reports - Улправда
Merger Talk: Will Leap Therapeutics Inc. stock attract ESG investorsQuarterly Profit Report & Short-Term High Return Ideas - Улправда
Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX) - Defense World
Transcript : Leap Therapeutics, Inc.Shareholder/Analyst Call - marketscreener.com
Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Leap Therapeutics Inc Azioni (LPTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| CAVANAUGH JAMES H | Director |
Nov 17 '25 |
Sale |
3.14 |
261,840 |
822,178 |
0 |
| ONSI DOUGLAS E | CEO,CFO,Pres.,GC,Treas.&Sec. |
Nov 17 '25 |
Sale |
3.14 |
676,319 |
2,123,642 |
2,136 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):